|
LDA NEWS & UPDATES
December 28, 2022
| |
|
Wishing you good times, good cheer and a healthy New Year!
All of us at the Lyme Disease Association (LDA) thank you for your support in 2022.
Let’s continue to work together in 2023 to find a cure.
| |
- Spent ~95% of all incoming monies on programs
- Not charged membership fees
- Funded research recognized in 60 peer-reviewed publications
- Awarded 123 research grants since 1992
- Awarded 159+ education grants for other organizations to provide education
- Presented 21 Continuing Medical Education (CME) Conferences, most with Columbia
- Awarded 107 CME Lyme conference scholarships for health care providers & advocates
- Provided $419,000+ for medical aid grants for children since 2004 through LymeAid 4 Kids
- Presented hundreds of programs for public, businesses, schools, and health care providers
- Partnered with EPA PESP program/get rid of ticks
- Partnered under LDANet umbrella with dozens of Lyme organizations across US
- Partnered to open first endowed research center on Lyme at Columbia University
- Maintained a free Lyme/TBD Doctor Referral database for 14 years, newly updated
- Published a free monthly newsletter online: new research, activities, study opportunities
- Maintained a YouTube channel, Facebook and Twitter pages
- Been a Platinum Level member (transparency) on Candid (Guidestar)
- Been a member Combined Federal Campaign (CFC) - the only designated national Lyme charity!
- Mailed printed brochures ordered from website for only the cost of S&H
32 Years of Patients Helping Patients
*All donations are tax deductible to the extent allowed by law.
| | |
|
Pat Smith, President, Lyme Disease Association Inc, presented at the 7th Annual LymeMIND Virtual Conference on November 5, 2022, on the panel, Finding Your Voice and Fighting for the Future – A Discussion on Patient Advocacy, Clinician Education and Access to Care. Other panelists were Lorraine Johnson, CEO of LymeDisease.org and principal investigator of MyLymeData; and Elizabeth Maloney, MD, President of Partnership for Tick-Borne Diseases Education, with moderator, Bennett Nemser, PhD, Senior Program Officer of the Steven & Alexandra Cohen Foundation. Read more. | |
Natalie Rudenko, et al., published in Emerging Infectious Diseases, January 2023, “Confirmation of Borrelia garinii, United States.” Currently, Borrelia burgdorferi ss, B. garinii, and B. afzelii - members of the Borrelia burgdorferi sl complex - cause most Lyme disease throughout the world. Read more. | |
| |
|
Zhaobin Guo, et al, republished “Visualization of the Dynamics of Invasion and Intravasation of the Bacterium That Causes Lyme Disease in a Tissue Engineered Dermal Microvessel Model” in Advanced Science on December 19, 2022 (initially published September 25, 2022). The study’s objective was to better understand the dissemination of vector-borne pathogens, such as Borrelia burgdorferi (Bb), in particular, invasion and intravasation into circulation. Read more. | |
Following Senate passage by a 68-29 vote on Thursday, Dec. 22, the House passed an omnibus appropriations bill by a 221-205-1 vote on Friday, Dec. 23. The President is expected to sign the measure. To allow more time for full enactment of the omnibus, Congress passed a third continuing resolution for FY 2023 through Dec. 30, which was signed by the President on Friday, Dec.23. Read more. | |
|
Charles Hart, et al., published “Human attachment site preferences of ticks parasitizing in New York” in Scientific Reports on December 3, 2022. By coordinating tick submissions from the community regarding bite-site location prior to pathogen testing, the researchers were able to gather sufficient data to better understand life stage-specific body-segment preferences of primary human-biting tick species in the region. Read more. | |
| |
|
Evan M. Bloch, et al., published “Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States” in the November 2022 issue of Open Forum Infectious Diseases which provides the results of a study that examined a nationally representative sample of patient hospitalizations. Read more. | |
ContagionLive published the article “Lyme Disease Vaccine Shows Antibodies 6 Months after Completion” by Senior Editor, John Parkinson, on December 1, 2022. The article provides details of the most recent investigational outcomes for Pfizer and Valneva’s Lyme disease vaccine candidate, VLA15. Read more. | |
|
An article titled “New Virus Discovered in Swiss Ticks” published in Global Biodefense on December 7, 2022, provides information about Alongshan virus (ALSV), which was first discovered in China in 2017. For the first time, scientists at the University of Zurich have detected the novel virus in Swiss ticks. Read more. | |
| |
|
An article by Joe Graedon for The People’s Pharmacy titled “Brain Changes from COVID Affect Memory!” provides an overview of the latest research showing changes to the brain after COVID infections generally described as cognitive dysfunction or “brain fog.” The author addresses several ways that COVID affects the brain, even in the mildest cases, and includes results from a number of recent studies designed to better understand what is actually going on in the brain to cause a wide range of cognitive difficulties. Read more. | |
Public comments were due by midnight Eastern Time (ET) on December 21, 2022 per the Federal Register, 11.21.22, announcement from the Office of the Assistant Secretary of Health, Office of Secretary, Department of Health & Human Services, issuing an RFI (Request For Information) for developing a national strategy for the prevention and control of vector-borne diseases (VBD) in humans including Lyme and other tick-borne diseases. Read more. | |
| |
|
|
News Medical published “Specific bacteria in the bladder may indicate who is more prone to recurrent UTIs” on December 13, 2022, outlining the results of a study out of The University of Texas at Dallas.
The researchers found a strong correlation between beneficial bacteria and the use of estrogen hormone therapy in postmenopausal women. Read more.
| |
On December 16, 2022, Isabella Backman, et al, published “Yale Researchers Discover Possible ‘Brain Fog’ Treatment for Long COVID” on the “Research & Innovation” page of the Yale Medicine website. The article recounts the experience of Arman Fesharaki-Zadeh, MD, Ph.D., a Yale Medicine neuropsychiatrist, as he began to encounter patients who were experiencing significant, persistent cognitive problems after COVID-19 infections colloquially referred to as “brain fog.” Read more. | |
|
Mikhail Y.Kartashov, et al., published “Novel Flavi-like virus in ixodid ticks and patients in Russia” in Volume 14, Issue 2 of Ticks and Tick-borne Diseases on December 5, 2022 (Version of Record December 16, 2022). Read more. | |
| |
|
On December 5, 2022, John D Scott, et al., published “Molecular Detection of Anaplasma phagocytophilum, Babesia odocoilei, Babesia species and Borrelia burgdorferi Sensu Lato in Songbirds” in Journal of Biomedical Research & Environmental Sciences. Songbirds in North America (Order: Passeriformes) are parasitized by the blacklegged tick, Ixodes scapularis, larvae and nymphs. Songbirds transport ticks, but the study shows they are also hosts of tick-borne, zoonotic pathogens. Read more. | |
|
The Lyme Disease Association Inc. (LDA) does not charge any membership fees. Most of our
materials are free to download and most of our videos are free on YouTube. Our nationwide
doctor referral system is free to access. Printed brochures can be ordered for S&H only.
| |
888-366-6611 Toll Free Info Line
| | | | |
